2RT Laser Treatment for Dry AMD

A gentle, nanosecond laser treatment designed to slow progression of dry age-related macular degeneration and protect central vision.

FDA Approved

Advanced Technology

At a Glance

2RT laser treatment is a non-invasive laser therapy to slow disease progression and support retinal health.

2RT Retinal Rejuvenation Laser Therapy

Transparent pricing with optional finance plans and follow-up care included

Specialist retinal surgeons, advanced imaging diagnostics, and access to innovative laser therapies

London, Surrey, Sussex

Key Benefits

What is 2RT Laser Treatment?

2RT, also known as Retinal Rejuvenation Therapy, is a non-invasive laser treatment developed for people with early to intermediate dry age-related macular degeneration (AMD), the most common form of AMD where gradual degeneration of the macula affects central vision.

Using ultra-short nanosecond laser pulses, 2RT stimulates biological repair pathways within the retina without causing thermal damage. Unlike conventional retinal lasers, which rely on heat and can harm delicate tissues, 2RT delivers energy in billionths of a second and at very low intensity, preserving photoreceptors and supporting cells while encouraging healthier retinal pigment epithelium (RPE) activity.

The procedure is designed to reduce drusen, lipid-rich deposits beneath the retina that are a hallmark of dry AMD, and help slow progression toward advanced AMD or conversion to the more severe wet form.

Types of Treatment Available for Macular Degeneration

1

2RT Laser Treatment (Dry AMD)

2RT (Retinal Rejuvenation Therapy) is a non-invasive laser treatment designed for early to intermediate dry age-related macular degeneration. It uses ultra-short nanosecond laser pulses to stimulate natural retinal repair pathways without heat damage, helping to reduce drusen and slow progression toward advanced AMD.

2

Anti-VEGF Injections (Wet AMD)

For wet macular degeneration, treatment typically involves anti-VEGF medications delivered by injection into the eye. These drugs reduce abnormal blood vessel growth and leakage beneath the retina, helping to stabilise or improve vision when started early and delivered regularly.

3

Lifestyle & Nutritional Management

For early AMD, treatment often includes AREDS-based nutritional supplements, smoking cessation, UV protection, and regular monitoring. These measures support retinal health and may reduce the risk of progression, particularly in dry AMD.

Comparing Macular Degeneration Treatments

Your consultant will recommend the most appropriate option based on your AMD type, retinal findings, and overall eye health.

Procedure
Type

How it works

Best For

Pros

Cons

Procedure
Type

2RT Laser Treatment

How it works

Nanosecond laser stimulates retinal repair without heat damage

Best For

Early–intermediate dry AMD

Pros

Non-invasive; outpatient; aims to slow progression; minimal discomfort

Cons

Does not restore lost vision; not suitable for advanced AMD

Procedure
Type

Anti-VEGF Injections

How it works

Blocks abnormal blood vessel growth and leakage

Best For

Wet AMD

Pros

Proven to stabilise or improve vision; widely used

Cons

Requires repeat injections; ongoing treatment needed

Procedure
Type

Nutritional Supplements (AREDS)

How it works

Supports retinal health with antioxidants and minerals

Best For

Early or intermediate dry AMD

Pros

Easy to use; supports long-term eye health

Cons

Does not reverse damage; limited effect in advanced disease

What Are the Benefits and Risk of 2RT?

Your surgeon will speak with you about the benefits and risks involved before your procedure.

Frame 35 2

Benefits of 2RT Treatment:

Non-invasive and quick outpatient treatment

Aims to slow AMD progression before vision loss becomes severe

Encourages natural repair rather than destructive thermal effects

Minimal discomfort with short sessions

Frame 35 3

Risks/side effects (not exhaustive):

2RT does not restore lost vision but slows further decline

Results vary between individuals

Rare temporary effects may include transient blurring or mild retinal changes

Ongoing monitoring and repeat treatments may be recommended

Not Sure If You're Eligible?

Book a comprehensive eye examination to better understand your vision and available treatment options.

Who Is Suitable for 2RT?

Your surgeon will speak with you about your suitability prior to carrying out the procedure

Frame 35 4
2RT may be suitable if you:

Have early or intermediate dry AMD confirmed on retinal imaging

Show drusen deposits but not advanced geographic atrophy

Wish to slow disease progression and support retinal function

Are not yet candidates for wet AMD injection therapies

Frame 35 5
A detailed retinal assessment including OCT imaging is required to confirm eligibility. 2RT is not a cure for AMD but is intended to slow progression and preserve central vision over time.

Costs and Finance Options

At Centre for Sight, treatment pricing is straightforward and packaged to simplify your care plan: 

Initial Consultation: £465

This includes comprehensive tests such as Ocular Coherence Tomography (OCT) scans to determine your suitability for 2RT treatment.


Additional Procedures

Injection Therapy

Bespoke Price

Per Eye

Consultant-led retinal care and personalised treatment plan

Anti-VEGF injection therapy tailored to disease activity

Advanced diagnostic imaging at each visit

Outpatient treatment under local anaesthetic

Ongoing monitoring and follow-up schedule

Access to urgent advice and specialist retinal support

2RT Treatment Annual Package

From £2,293

Per Eye

Consultant-led retinal assessment and treatment planning

Two 2RT laser sessions per eye included

Non-invasive outpatient laser treatment

Advanced OCT and retinal imaging monitoring

Structured follow-up and ongoing review

Access to specialist macular care team

Cataract Surgery

From £3,602

Per Eye

Consultant-led cataract assessment and surgery

Choice of intraocular lens based on clinical suitability

Laser-assisted cataract surgery where appropriate

Advanced diagnostic imaging and surgical planning

Day-case procedure under local anaesthetic

24-hour emergency support and structured aftercare

Flexible Financing Options

Private Medical Insurance

Many of our consultants work with all of the major insurance providers.*

Self Pay

Pay in full for patients who prefer a straightforward approach.

Interest Free Finance

6-24 month finance options. Credit is provided subject to affordability, age and status. Minimum spend applies.

Military Discount

5% discount for active military and veterans.

* Private Medical Insurance is unlikely to cover Laser Eye Surgery procedures, Implantable Contact Lenses or Laser Lens Replacement

*Private Medical Insurance is unlikely to cover Laser Eye Surgery Procedures, Implantable Contact Lenses, Laser Lens Replacement or any other cosmetic procedures.

FAQs

Below are answers to some of the most frequently asked questions about 2RT treatment, to help you understand whether it may be right for you.

Yes, 2RT is considered exceptionally safe. The nanosecond laser technology minimises risks by using very lowenergy. Side effects are rare but may include temporary blurred vision or mild redness.

The treatment is suitable for patients in the early to intermediate stages of dry AMD. A detailed evaluation, including OCT scans, determines eligibility. 

2RT does not cure AMD but significantly slows its progression. It can preserve your current level of vision and reduce the risk of developing the more severe wet form of AMD.

Since AMD is a chronic condition, ongoing monitoring and treatments every six months are recommended to manage the disease effectively.

Risks are minimal. Rare complications may include slight retinal changes, minor bleeding, or transient vision changes, which are usually temporary and resolve on their own.

Guymer R, Brassington K, Dimitrov P et al., Clin Experiment Ophthalmology 2013 Oct 3. Doi:10.1111/ceo.12247

Guymer RH, Wu Z, Hodgson LAB, et al. Subthreshold Nanosecond Laser Intervention in Age Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Ophthalmology 2019 Jun; 126(6):829-838

Fletcher EL, et al. Nanosecond laser therapy reverses pathological and molecular changes in age related macular degeneration without retinal damage. Federation of American Societies of Experimental Biology. November 2014; 28 (11).

Casson RJ. et al., Pilot randomized trial of a nanopulse retinal laser versus conventional photocoagulation for the treatment of diabetic macular oedema. Clin Experiment Ophthalmol.
2012 Aug;40(6):604–10

Pelosini L, Hamilton R, Mohamed M, et al. Retina Rejuvenation Therapy for Diabetic Macula Edema. A pilot study. Retina. 2012;0:1 –11.

Vessey KA, Ho T, Jobling AI, et al. Nanosecond laser treatment for age-related macular degeneration does not induce focal vision loss or new vessel growth in the retina. Invest Ophthalmol Vis Sci. 2018;59:731 –745.

Chidlow G, Plunkett M, Casson RJ, et al. Investigations into localized re-treatment of the retina with a 3-nanosecond laser. Lasers Surg. Med. 2016;48(6):602–615.

Jobling AI, Guymer RH, Vessey KA, et al. Nanosecond laser therapy reverses pathologic and molecular changes in agerelated macular degeneration.

Chidlow G, Shibeeb OS, Plunkett M, et al. Glial Cell and Inflammatory Responses to Retinal Laser Treatment: Comparison of a Conventional Photocoagulator and a Novel, 3-Nanosecond Pulse Laser. IOVS. 2013;54(3):2319– 2332.

Wood JPM, Shibeeb OS, Plunkett M, et al. Retinal Damage Profiles and Neuronal Effects of Laser Treatment: Comparison of a Conventional Photocoagulator and a Novel 3-Nanosecond Pulse Laser. IOVS. 2013;54(3):2305–2318b

Have Questions?

Our patient care team is here to answer any questions you may have.

Patient Success Stories

Videos

About Centre for Sight

Centre for Sight Virtual Tour

Certifications & Recognition

The Power List 2026

Global Top 50: Mr. Sheraz Daya

Top 1% Surgeons

National recognition

CQC Accredited

Highest safety standards

5-Star Rated

Patient satisfaction